Erica Nelson, MD

Erica Nelson, MD

Division Chief, General Obstetrics & Gynecology
Obstetrics and Gynecology
Accepting new patients
Call for an appointment
217-545-8000
or
Request appointment

    About me

     

    Gender

    Female

    Education & training

    Positions
    Associate Professor
    Division Chief, General Obstetrics & Gynecology
    Director, Obstetrics & Gynecology Residency Program
    Board Certifications
    Obstetrics & Gynecology
    Medical School
    College of Medicine, University of Vermont, Burlington, VT
    Undergraduate Degree
    Undergraduate, BA Biochemistry, Pomona College
    Residency
    Oregon Health Sciences University, Portland, OR - Obstetrics and Gynecology

    Specialties

    Treatments & procedures

    Patient waiting for appointment

    Appointments

    SIU Medicine strongly encourages all patients to verify coverage, benefits and which providers are considered in-network with their health plan. SIU Medicine has more than 300 health care providers ready to serve you and your family. SIU Medicine accepts a wide variety of governmental and non-governmental health plans to serve our community. 

    Clinical locations

    Locations

    SIU OB-GYN at HSHS St. John's Health Center

    1100 Lincolnshire Blvd. Springfield, IL 62703 Suite 200
    Get Directions
    Mon - Fri: 8:00 am-4:30 pm
    217-545-8000
    Locations

    SIU OB-GYN at HSHS St. Francis Hospital

    1215 Franciscan Dr. Litchfield, IL 62056 4th Floor
    Get Directions
    217-545-8000

    Hospital privileges

    • HSHS St. Francis Hospital, Litchfield IL
    • HSHS St. John's Hospital, Springfield, IL
    • Memorial Health, Springfield IL

    Clinical trials

    Trial
    Obstetrics and Gynecology

    Biomarkers for Endometrial and Ovarian Cancer

    Active recruiting

    PURPOSE: This is a biological sample collection study aimed at developing an early diagnostic tool for endometrial and ovarian cancer. The investigators are studying the relationship between estrogen driven gynecological cancers, inflammation and the microbiome. Patients who have been diagnosed with endometrial cancer or undergo presurgical evaluation for suspicion of ovarian cancer who are scheduled for a hysterectomy, bilateral oophorectomy and/or salpingectomy are eligible. Control patients undergoing gynecological surgery for benign indications are also being recruited.

    Contact: Kathleen Groesch 217-545-6671